Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Advances in Brief

Gelsolin: A Candidate for Suppressor of Human Bladder Cancer

Motoyoshi Tanaka, Leonhard Müllauer, Yoshifumi Ogiso, Hisakazu Fujita, Shingo Moriya, Keiji Furuuchi, Tohru Harabayashi, Nobuo Shinohara, Tomohiko Koyanagi and Noboru Kuzumaki
Motoyoshi Tanaka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonhard Müllauer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshifumi Ogiso
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hisakazu Fujita
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shingo Moriya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keiji Furuuchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tohru Harabayashi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuo Shinohara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomohiko Koyanagi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noboru Kuzumaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published August 1995
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Human transitional cell carcinomas of the bladder frequently reveal chromosomal abnormalities that span a range between chromosome 9p12 and 9qter, even at early stages of bladder carcinogenesis. Because the gene that encodes an actin-regulatory protein, gelsolin, is localized in chromosome 9q33, we examined the expression of gelsolin in a number of human bladder cancer cell lines and tissues. In all 6 cell lines and in 14 of the 18 tumor tissues (77.8%), gelsolin expression was undetectable or extremely low in comparison with its expression in normal bladder epithelial cells. Furthermore, upon the introduction of the exogenous human or mouse authentic gelsolin cDNA into a human bladder cancer cell line, UMUC-2, gelsolin transfectants of UMUC-2 greatly reduced the colony-forming ability and the tumorigenicity in vivo. These results suggest that gelsolin plays a key role as a tumor suppressor in human urinary bladder carcinogenesis.

Footnotes

  • ↵1 This work was supported in part by a grant-in-aid from the Ministry of Education, Science and Culture, Japan.

  • ↵3 To whom requests for reprints should be addressed.

  • Received March 7, 1995.
  • Accepted June 15, 1995.
  • ©1995 American Association for Cancer Research.
PreviousNext
Back to top
August 1995
Volume 55, Issue 15
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Gelsolin: A Candidate for Suppressor of Human Bladder Cancer
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Gelsolin: A Candidate for Suppressor of Human Bladder Cancer
Motoyoshi Tanaka, Leonhard Müllauer, Yoshifumi Ogiso, Hisakazu Fujita, Shingo Moriya, Keiji Furuuchi, Tohru Harabayashi, Nobuo Shinohara, Tomohiko Koyanagi and Noboru Kuzumaki
Cancer Res August 1 1995 (55) (15) 3228-3232;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Gelsolin: A Candidate for Suppressor of Human Bladder Cancer
Motoyoshi Tanaka, Leonhard Müllauer, Yoshifumi Ogiso, Hisakazu Fujita, Shingo Moriya, Keiji Furuuchi, Tohru Harabayashi, Nobuo Shinohara, Tomohiko Koyanagi and Noboru Kuzumaki
Cancer Res August 1 1995 (55) (15) 3228-3232;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Advances in Brief

  • Down-Regulation of Regulatory Subunit Type 1A of Protein Kinase A Leads to Endocrine and Other Tumors
  • Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
  • 2-Arachidonoylglycerol
Show more Advances in Brief

Articles

  • Down-Regulation of Regulatory Subunit Type 1A of Protein Kinase A Leads to Endocrine and Other Tumors
  • Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
  • 2-Arachidonoylglycerol
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement